Read Summary

The presence of Hashimoto thyroiditis lowers the risk of recurrence of BRAF mutation-positive or mutation-negative differentiated thyroid cancer. BRAF V600E mutation is a negative prognostic factor.
Medscape Medical News

Print Friendly, PDF & Email